Qureight is proud to announce that we have achieved ISO 27001 certification, the globally recognised benchmark for excellence in information security management systems. This milestone highlights our commitment to safeguarding sensitive data and establishing greater trust within our partners and stakeholder community.
Why ISO 27001 matters
ISO 27001 certification signifies that Qureight has implemented a comprehensive framework to identify, manage, and mitigate information security risks across the business. This is especially important in healthcare and life sciences because any breaches or mismanagement could compromise patient privacy, erode trust, and hinder progress for innovation in data curation and management.
By adhering to the gold standard in information security, we establish ourselves as a trusted partner capable of navigating complex global regulatory landscapes while delivering high-quality, secure results.
What this means for our research partners
Our work involves handling real-world data accessed through our partner healthcare institutions worldwide. Managing this data responsibly is critical, not only for regulatory compliance but also to protect the people most affected by breaches or misuse.
ISO 27001 certification assures our partners, pharmaceutical companies, contract research organisations (CROs), and healthcare providers alike, that we are adhering to these rigorous standards. This can enable smoother collaborations, reduce risks, and improve access to the high-quality data we need to develop cutting-edge therapies.
Why data security matters in clinical trials
The world of clinical trials is evolving rapidly, with vast amounts of sensitive patient data at the core of this transformation. At Qureight, we’ve implemented advanced measures such as encryption, access controls, and rigorous monitoring systems to ensure that patient clinical trial data remains confidential, secure, and compliant with all relevant regulations.
The standard also reduces blockers to innovation in AI and ML, and enables clinical applications to develop more rapidly, like accelerating treatments for idiopathic pulmonary fibrosis (IPF), pulmonary hypertension and lung cancer.
A milestone in our journey
Achieving ISO 27001 certification is a significant step forward for the company. As we continue to innovate in the healthcare and clinical research space, our focus remains on providing secure and compliant solutions - advancing Qureight’s AI capabilities, and furthering our ability to understand complex data and accelerate drug development.